The usefulness of current psychiatric classification, which is based on ICD/DSM categorical
diagnoses, remains questionable. A promising alternative has been put forward as the …

Second‐generation antipsychotics (SGAs) are recommended for maintenance treatment in
schizophrenia. However, comparative long‐term effectiveness among SGAs is unclear. Here …

Introduction Antipsychotics (AP) induce weight gain. However, reviews and meta-analyses
generally are restricted to second generation antipsychotics (SGA) and do not stratify for …

Tardive dyskinesia (TD) risk with D2/serotonin receptor antagonists or D2 receptor partial
agonists (second‐generation antipsychotics, SGAs) is considered significantly lower than …

Background In many countries of the industrialised world second generation (" atypical")
antipsychotics have become the first line drug treatment for people with schizophrenia. The …

Antipsychotic-induced weight gain is an important issue in the treatment of psychotic
illnesses, and affects 80% of individuals being treated with antipsychotic drugs. However …

These updated guidelines are based on the first edition of the World Federation of Societies
of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia …

Data from two major government-funded studies of comparative antipsychotic effectiveness
in schizophrenia contradict the widely prevalent belief that the newer second-generation …

The prevalence of overweight and obesity is higher in people with mental illness than in the
general population. Body weight is tightly regulated by a complex system involving the …

Очередное, четвертое издание монографии, посвященной проблеме депрессий. В
книге, выполненной через 11 лет после выхода в свет в 2003 г. предыдущего издания …